In re: Cytophil, Inc.

CourtUnited States Bankruptcy Court, E.D. Wisconsin
DecidedJune 12, 2026
Docket25-20576
StatusUnknown

This text of In re: Cytophil, Inc. (In re: Cytophil, Inc.) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, E.D. Wisconsin primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re: Cytophil, Inc., (Wis. 2026).

Opinion

So Ordered.

Dated: June 12, 2026 Wel J A. . Michael Halfenger United States Bankruptcy Judge

UNITED STATES BANKRUPTCY COURT FOR THE EASTERN DISTRICT OF WISCONSIN

In re: Cytophil, Inc., Case No. 25-20576-gmh Chapter 11 Debtor.

OPINION, FINDINGS OF FACT, CONCLUSIONS OF LAW, AND ORDER ON HEALTH POLICY ASSOCIATES, INC.’S OBJECTION TO CLAIM NUMBER 10 OF JANSSON MUNGER & MCKINLEY LTD.

Creditor Health Policy Associates, Inc., objects that creditor Jansson Munger & McKinley Ltd.’s claim for breach of contract is barred in substantial part by Wisconsin’s statute of limitations. Precedent demonstrates that the claim is timely. In June 2015 Merz North America, Inc. (Merz) sued Cytophil, Inc., in the United States District Court for the Eastern District of North Carolina alleging that Cytophil’s Renti® Voice injectable vocal fold implant infringed Merz’s patent. Merz N. Am., Inc. v.

Cytophil, Inc., No. 5:15-cv-262, ECF No. 1 (E.D.N.C. June 18, 2015).1 In August 2015 Cytophil engaged Jansson Munger & McKinley Ltd. (Jansson or the firm) to represent it in its litigation with Merz.2 Ex. 101. Firm lawyers Peter and Eric Jansson filed notices of appearance in the North Carolina case on September 29, 2015; two days later they filed Cytophil’s motion to dismiss that case, contending that the court lacked jurisdiction and that venue was improper. Merz N. Am. Inc. v. Cytophil, No. 5:15-cv-00262, ECF Nos. 23– 26. In April 2016, Cytophil—represented by Jansson as part of the same engagement—filed a complaint against Merz and its parent company in the United States District Court for the Eastern District of Wisconsin alleging that those parties had engaged in false marking under the §292 of the Patent Act, 35 U.S.C. §292, and unlawful monopolization under §2 of the Sherman Act, 15 U.S.C. §2. Cytophil, Inc. v. Merz N. Am. Inc., 2:16-cv-00423, ECF No. 1 (E.D. Wis. Apr. 6, 2016). In August 2016, Judge Adelman transferred the Eastern District of Wisconsin case to the Eastern District of North Carolina, which jointly administered the cases until their conclusion. Id. at ECF No. 67; see also Merz N. Am., Inc. v. Cytophil, Inc., No. 5:15-cv-00262, ECF No. 191. After about four years of proceedings before District Judge Howard and Magistrate Judge Swank, including discovery, extensive motion practice, and a Markman3 claim-construction

1. The court takes judicial notice of the public records in the Merz litigation, specifically the records in Merz N. Am., Inc. v. Cytophil, Inc., No. 5:15-cv-00262 (E.D.N.C. filed June 18, 2015), and Cytophil, Inc. v. Merz N. Am. Inc., 2:16-cv-00423 (E.D. Wis. filed April 6, 2016), to provide context for the parties’ current dispute. See Fed. R. Evid. 201(b) & (c)(1); see also Gen. Elec. Cap. Corp. v. Lease Resol. Corp., 128 F.3d 1074, 1081 (7th Cir. 1997) (“‘The most frequent use of judicial notice of ascertainable facts is in noticing the contents of court records.’” (quoting 21 Charles Alan Wright & Kenneth W. Graham, Jr., Fed. Prac. & Pro.: Evid. § 5106, at 505 (1st ed. 1977 & Supp. 1997))). Jansson’s pretrial brief requested that the court take judicial notice of those court records (ECF No. 240, at 2 n.1), and HPA did not object to that course. See Fed. R. Evid. 201(c)(2) & (e). 2. When the engagement letter was executed, the law firm’s name was Jansson Munger McKinley & Shape Ltd. Ex. 101, at 1. The proof of claim was filed by Jansson Munger & McKinley Ltd. See Claim No. 10. 3. Markman v. Westview Instrs., Inc., 517 U.S. 370 (1996). hearing, the parties reached a mediated settlement that resulted in the dismissal of all claims on June 6, 2019. Merz N. Am., Inc. v. Cytophil, Inc., No. 5:15-cv-262, ECF No. 313; see also Case No. 25-20576, Evidentiary Hr’g Test., ECF No. 245. B Although Cytophil made regular partial payments to Jansson through April 2018, Cytophil owed the firm more than $1.3 million when the litigation concluded in 2019. See Exs. 3 & 4. In April 2025, Jansson filed proof of claim number 10, alleging that Cytophil owed it $1,327,902.28 in unpaid legal fees. Claim No. 10-1. Jansson supported the claim with ledgers showing Cytophil’s indebtedness for services rendered in the Merz litigation and those ledgers reflect charges that the firm had invoiced from 2015 to 2019.4 Id. at Parts 5 & 6; Exs. 3 & 4. Cytophil does not contest Jansson’s claim. It scheduled Jansson as holding a nonpriority unsecured claim for $1,327,902.28 that is liquidated and undisputed. ECF No. 36, at 12. Health Policy Associates, Inc. (HPA), which asserts a (roughly) $727 thousand default judgment claim against Cytophil, objects to the allowance of Jansson’s claim in its full amount, contending that Jansson’s alleged damages are mostly time-barred by Wisconsin’s six-year statute of limitations and thus are not allowable under 11 U.S.C. §502(b)(1). See 11 U.S.C. §502(b)(1) (“. . . if such objection to a claim is made, the court, after notice and a hearing, shall determine the amount of such claim . . . as of the date of filing the petition, and shall allow such claim in such amount, except to the extent that—(1) such claim is unenforceable against the debtor . . . under any . . . applicable law . . .”); ECF No. 113, at 4–6; ECF No. 241, at 2–5; & ECF No. 251. HPA argues that Jansson’s invoices were due on receipt; as a result, Jansson’s bankruptcy claim may only

4. While the firm treated its representation of Cytophil against Merz as a single engagement, it kept separate ledgers for the defense of the patent claims and prosecution of Cytophil’s false marking and antitrust claims to preserve Cytophil’s ability to recover its legal fees from Merz, including under 35 U.S.C. §285, if it prevailed in the litigation. Case No. 25-20576, Evidentiary Hr’g Test., ECF No. 245. be allowed to the extent it consists of fees that Jansson first invoiced within six years of the date on which Cytophil filed its bankruptcy petition—invoices totaling only about $204 thousand. ECF No. 241, at 4. HPA contends that the remainder of Jansson’s claim is not allowable under §502(b)(1) because each earlier unpaid invoice constitutes a separate contract cause of action that accrued more than six years before the debtor filed for bankruptcy and thus is barred by Wisconsin’s six-year statute of limitations, Wis. Stat. §893.43(1). Jansson responds (among other things) that it holds a single claim for unpaid fees for representing Cytophil in the Merz litigation and that a total breach of the engagement agreement did not occur—thus its breach of contract claim did not accrue—until the representation ended in June 2019 and Cytophil failed to pay the amounts owed.5 ECF No. 240, at 7–8 & ECF No. 250. Therefore, Jansson argues, its claim—the validity of which is determined as of February 4, 2025, the date on which Cytophil filed its bankruptcy petition (see §502(b)(1))—is timely under Wisconsin’s six- year statute of limitations.6 ECF No.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

BMD CONTRACTORS v. Fidelity and Deposit Co. of Md.
679 F.3d 643 (Seventh Circuit, 2012)
Seyburn, Kahn, Ginn, Bess, Deitch & Serlin, PC v. Bakshi
771 N.W.2d 411 (Michigan Supreme Court, 2009)
State v. Holland Plastics Co.
331 N.W.2d 320 (Wisconsin Supreme Court, 1983)
Segall v. Hurwitz
339 N.W.2d 333 (Court of Appeals of Wisconsin, 1983)
Pritzlaff v. Archdiocese of Milwaukee
533 N.W.2d 780 (Wisconsin Supreme Court, 1995)
CLL Associates Ltd. Partnership v. Arrowhead Pacific Corp.
497 N.W.2d 115 (Wisconsin Supreme Court, 1993)
Noonan v. Northwestern Mutual Life Insurance
2004 WI App 154 (Court of Appeals of Wisconsin, 2004)
Matchett v. Rose
344 N.E.2d 770 (Appellate Court of Illinois, 1976)
Jensen v. Janesville Sand & Gravel Co.
415 N.W.2d 559 (Court of Appeals of Wisconsin, 1987)
Felt v. Mitchell
88 N.E. 723 (Indiana Court of Appeals, 1909)
Walker v. Goodrich
16 Ill. 341 (Illinois Supreme Court, 1855)
Allen v. Transamerica Insurance
128 F.3d 462 (Seventh Circuit, 1997)
Pellettieri v. Protopapas
890 A.2d 1022 (New Jersey Superior Court App Division, 2006)
Doe v. State
579 A.2d 37 (Supreme Court of Connecticut, 1990)
Mitchell v. Guardian Systems, Inc.
804 A.2d 1004 (Connecticut Appellate Court, 2002)
Wilson v. Wilson
75 P.2d 277 (Supreme Court of Kansas, 1938)
Lowe v. Ring
82 N.W. 571 (Wisconsin Supreme Court, 1900)
Sanchelima Int'l, Inc. v. Walker Stainless Equip. Co.
920 F.3d 1141 (Seventh Circuit, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
In re: Cytophil, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-cytophil-inc-wieb-2026.